Publicacións nas que colabora con Javier Conde Aranda (41)

2022

  1. Analgesic and antiinflammatory effects of Nigella orientalis L. seeds fixed oil: Pharmacological potentials and molecular mechanisms

    Phytotherapy Research, Vol. 36, Núm. 3, pp. 1372-1385

  2. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. An update on the role of leptin in the immuno-metabolism of cartilage

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-16

  2. Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway

    Cartilage, Vol. 13, Núm. 2, pp. 925S-934S

  3. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib

    Journal of Ethnopharmacology, Vol. 272

  4. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes

    Laboratory Investigation, Vol. 101, Núm. 12, pp. 1550-1560

2020

  1. Levels of the novel endogenous antagonist of ghrelin receptor, liver-enriched antimicrobial peptide-2, in patients with rheumatoid arthritis

    Nutrients, Vol. 12, Núm. 4

2018

  1. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways

    Cellular Physiology and Biochemistry, Vol. 49, Núm. 6, pp. 2414-2426

2017

  1. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

  2. Progranulin as a biomarker and potential therapeutic agent

    Drug Discovery Today, Vol. 22, Núm. 10, pp. 1557-1564

2016

  1. E74-like factor 3 and nuclear factor-κB regulate lipocalin-2 expression in chondrocytes

    Journal of Physiology, Vol. 594, Núm. 21, pp. 6133-6146

  2. Pollutants make rheumatic diseases worse: Facts on polychlorinated biphenyls (PCBs) exposure and rheumatic diseases

    Life Sciences, Vol. 157, pp. 140-144

  3. The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1

    Scientific Reports, Vol. 6

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  2. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  3. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

    Biomarkers, Vol. 20, Núm. 8, pp. 565-571

2014

  1. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

  2. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

  3. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  4. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases